Video versus phone education for people getting breast radiotherapy
Official title: Virtual Vs Telephone Education in Radiotherapy - Randomized Clinical Trial
Run by University Health Network, Toronto · NCT07255196 · Data updated 2026-11-12
This study will test whether a 45-minute videoconference education session, compared with a 30-minute phone call, reduces treatment fears and improves satisfaction for adults receiving breast radiotherapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 130 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | December 20, 2025 |
| Main results expected | July 2026 |
| Study ends | December 2026 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT07255196 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with breast cancer who are scheduled for radical radiotherapy, have access to an internet-connected device with a microphone and camera, and can communicate in English (with or without a translator) are ideal candidates.
✕Probably not a fit
Patients without reliable internet or a camera/microphone, those with prior radiotherapy, or those not treated at the study center are unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Breast cancer patients scheduled for radical radiotherapy will receive pre-treatment education either by a 45-minute radiation therapist–led videoconference or the current 30-minute telephone education. Participants will complete questionnaires at three time points to measure procedural fears and concerns, anxiety levels, and patient satisfaction. The intervention focuses on delivering more visual and interactive information via videoconferencing compared with standard audio-only telephone calls. The study is conducted through Princess Margaret Cancer Centre and enrolls adults who have internet-connected devices with a camera and microphone.
Why it matters
Potential benefit: If successful, videoconference education could lower patients' procedural fears and anxiety and increase satisfaction with pre-radiotherapy preparation.
How similar studies have gone: Small studies, including work by Magliozzi et al., have reported higher patient satisfaction with videoconferencing versus telephone, but direct comparative evidence is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Access to an internet connected device with a microphone and camera * Able to communicate in English with/without a translator * Receiving radical breast cancer radiotherapy Exclusion Criteria: * Previous radiotherapy treatment
Where it's running
-
Princess Margaret Cancer Center
Toronto, Ontario, Canada Recruiting
Study contacts
- Study coordinator: Michael Velec, PhD
- Email: michael.velec@uhn.ca
- Phone: 416-946-4501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing an AI avatar video versus a conventional narrated PowerPoint to teach patients about radiotherapy
This study will test whether an AI-generated avatar video helps adults scheduled for radiotherapy understand their treatment better and feel less anxious compared with a conventional narrated PowerPoint video.
-
Analysis of outcomes and side effects in patients receiving radiation therapy
This study looks at the results and side effects of radiation therapy in patients at Winterthur Cantonal Hospital to see how treatment can be improved for future patients.
-
Primary tumor removal with targeted lymph node removal plus radiation for biliary tract cancer with lymph node spread
This phase II study tests whether removing the main tumor and select nearby lymph nodes, followed by postoperative radiation, helps patients with biliary tract cancer and lymph node metastases.
-
Tributyrin as a dietary supplement to help prevent radiation-induced rectal injury during rectal cancer chemoradiation
This study tests whether adding tributyrin to standard chemoradiotherapy helps prevent acute radiation-induced rectal injury in people with locally advanced rectal cancer.
-
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant NSCLC
This trial tests a targeted induction approach using fumetinib with platinum-based chemotherapy and concurrent radiochemotherapy in adults with unresectable stage III EGFR-mutant NSCLC to see if this combo can improve outcomes before possible surgery.
-
Virtual vs in-person follow-up visits after radiotherapy
This study tests whether telehealth follow-ups during radiotherapy are practical and satisfactory for patients and physicians, compared to in-person visits.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.